CEFTRIAXONE VIATRIS 1 g, poudre pour solution injectable, Clarithromycine EG 500 mg comprimés pelliculés, MÉTRONIDAZOLE ARROW 500 mg, comprimé pelliculé sécable
APHP220670
Phase 3 small_molecule active
Quick answer
CEFTRIAXONE VIATRIS 1 g, poudre pour solution injectable, Clarithromycine EG 500 mg comprimés pelliculés, MÉTRONIDAZOLE ARROW 500 mg, comprimé pelliculé sécable for Pregnant women with singleton pregnancies hospitalized for threatened late miscarriage with intact membranes is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Pregnant women with singleton pregnancies hospitalized for threatened late miscarriage with intact membranes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active